Patent · US Active

In situ antigen-generating cancer vaccine

US9486512B2 · kind B2 · utility

30Cited by
41References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2012
Grant dateNov 8, 2016
Priority date—
Expiry dateJun 20, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/70
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.